BAIAP2 and attention deficit-hyperactivity disorder: Recent studies have associated IRSp53/Baiap2 with various psychiatric disorders, including autism spectrum disorder (ASD) [57], attention-deficit/hyperactivity disorder (ADHD) [58] and schizophrenia [59].